FDA authorizes possible coronavirus remedy remdesivir for emergency use

Published May 1, 2020 8:14pm ET



The Food and Drug Administration granted emergency use authorization Friday for remdesivir, a medication researchers believe could treat patients diagnosed with COVID-19.

“We want to thank the collaborators that brought remdesivir to this point and many of our people that have been part of this, in fact, the caregivers,” Gilead CEO Daniel O’Day told reporters Friday.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.